Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques

Atherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbo...

Full description

Bibliographic Details
Main Authors: Shamil Akhmedov, Sergey Afanasyev, Marina Trusova, Pavel Postnikov, Yulia Rogovskaya, Elena Grakova, Kristina Kopeva, Rosa Karen Carreon Paz, Sascha Balakin, Hans-Peter Wiesmann, Joerg Opitz, Benjamin Kruppke, Natalia Beshchasna, Sergey Popov
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/7/802
_version_ 1797527586358689792
author Shamil Akhmedov
Sergey Afanasyev
Marina Trusova
Pavel Postnikov
Yulia Rogovskaya
Elena Grakova
Kristina Kopeva
Rosa Karen Carreon Paz
Sascha Balakin
Hans-Peter Wiesmann
Joerg Opitz
Benjamin Kruppke
Natalia Beshchasna
Sergey Popov
author_facet Shamil Akhmedov
Sergey Afanasyev
Marina Trusova
Pavel Postnikov
Yulia Rogovskaya
Elena Grakova
Kristina Kopeva
Rosa Karen Carreon Paz
Sascha Balakin
Hans-Peter Wiesmann
Joerg Opitz
Benjamin Kruppke
Natalia Beshchasna
Sergey Popov
author_sort Shamil Akhmedov
collection DOAJ
description Atherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbon-coated iron nanoparticles (Fe@C NPs) were produced by gas-phase synthesis and modified with organic functional groups of a lipophilic nature. Modified and non-modified Fe@C NPs, immobilized with polycaprolactone on stainless steel, showed high cytocompatibility in human endothelial cell culture. Furthermore, after ex vivo treatment of native atherosclerotic plaques obtained during open carotid endarterectomy surgery, Fe@C NPs penetrated the inner structures and caused structural changes of atherosclerotic plaques, depending on the period of implantation in Wistar rats, serving as a natural bioreactor. The high biocompatibility of the Fe@C NPs shows great potential in the treatment of atherosclerosis disease as an active substance of stent coatings to prevent restenosis and the formation of atherosclerotic plaques.
first_indexed 2024-03-10T09:44:51Z
format Article
id doaj.art-400cf5484b5148a491f0eab7f66d20ab
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T09:44:51Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-400cf5484b5148a491f0eab7f66d20ab2023-11-22T03:17:16ZengMDPI AGBiomedicines2227-90592021-07-019780210.3390/biomedicines9070802Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic PlaquesShamil Akhmedov0Sergey Afanasyev1Marina Trusova2Pavel Postnikov3Yulia Rogovskaya4Elena Grakova5Kristina Kopeva6Rosa Karen Carreon Paz7Sascha Balakin8Hans-Peter Wiesmann9Joerg Opitz10Benjamin Kruppke11Natalia Beshchasna12Sergey Popov13Tomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaTomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, RussiaResearch School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, RussiaTomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaTomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaTomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaFraunhofer Institute for Ceramic Technologies and Systems IKTS, 01109 Dresden, GermanyFraunhofer Institute for Ceramic Technologies and Systems IKTS, 01109 Dresden, GermanyMax Bergmann Center of Biomaterials, Institute of Materials Science, Technische Universität Dresden, 01069 Dresden, GermanyFraunhofer Institute for Ceramic Technologies and Systems IKTS, 01109 Dresden, GermanyMax Bergmann Center of Biomaterials, Institute of Materials Science, Technische Universität Dresden, 01069 Dresden, GermanyFraunhofer Institute for Ceramic Technologies and Systems IKTS, 01109 Dresden, GermanyTomsk National Research Medical Center of the Russian Academy of Sciences, Cardiology Research Institute, 634012 Tomsk, RussiaAtherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbon-coated iron nanoparticles (Fe@C NPs) were produced by gas-phase synthesis and modified with organic functional groups of a lipophilic nature. Modified and non-modified Fe@C NPs, immobilized with polycaprolactone on stainless steel, showed high cytocompatibility in human endothelial cell culture. Furthermore, after ex vivo treatment of native atherosclerotic plaques obtained during open carotid endarterectomy surgery, Fe@C NPs penetrated the inner structures and caused structural changes of atherosclerotic plaques, depending on the period of implantation in Wistar rats, serving as a natural bioreactor. The high biocompatibility of the Fe@C NPs shows great potential in the treatment of atherosclerosis disease as an active substance of stent coatings to prevent restenosis and the formation of atherosclerotic plaques.https://www.mdpi.com/2227-9059/9/7/802atherosclerosishigh density lipoproteinchemically modified carbon-coated iron nanoparticlereverse cholesterol transportmacrophagecoronary stent
spellingShingle Shamil Akhmedov
Sergey Afanasyev
Marina Trusova
Pavel Postnikov
Yulia Rogovskaya
Elena Grakova
Kristina Kopeva
Rosa Karen Carreon Paz
Sascha Balakin
Hans-Peter Wiesmann
Joerg Opitz
Benjamin Kruppke
Natalia Beshchasna
Sergey Popov
Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
Biomedicines
atherosclerosis
high density lipoprotein
chemically modified carbon-coated iron nanoparticle
reverse cholesterol transport
macrophage
coronary stent
title Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
title_full Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
title_fullStr Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
title_full_unstemmed Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
title_short Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
title_sort chemically modified biomimetic carbon coated iron nanoparticles for stent coatings in vitro cytocompatibility and in vivo structural changes in human atherosclerotic plaques
topic atherosclerosis
high density lipoprotein
chemically modified carbon-coated iron nanoparticle
reverse cholesterol transport
macrophage
coronary stent
url https://www.mdpi.com/2227-9059/9/7/802
work_keys_str_mv AT shamilakhmedov chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT sergeyafanasyev chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT marinatrusova chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT pavelpostnikov chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT yuliarogovskaya chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT elenagrakova chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT kristinakopeva chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT rosakarencarreonpaz chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT saschabalakin chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT hanspeterwiesmann chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT joergopitz chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT benjaminkruppke chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT nataliabeshchasna chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques
AT sergeypopov chemicallymodifiedbiomimeticcarboncoatedironnanoparticlesforstentcoatingsinvitrocytocompatibilityandinvivostructuralchangesinhumanatheroscleroticplaques